Final report of University Hospital Hradec Kralove to the clinical trial protocol no. TS-P04834

Abstract

Realization of a part of clinical trial called multicenter, randomized, double-blind, active-controlled study - Phase 3 monitoring of safety and efficacy of rolapitant in preventing chemotherapy-induced nausea and vomiting (CINV) in subjects receiving moderate emetogenic chemotherapy (MEC)

Keywords

• rolapitant
• chemotherapy-induced nausea and vomiting
• moderate emetogenic chemotherapy